Vimarsana
Biggest News Aggregation in the World

Page 3 - Graphite Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Graphite Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Graphite Bio Today - Breaking & Trending Today

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - Vimarsana News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of

BALA CYNWYD, Pa., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...

Freeline, after cuts, agrees to take-private deal with Syncona - Vimarsana News

Freeline, after cuts, agrees to take-private deal with Syncona

BioPharma

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH - Vimarsana News

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

18.11.2023 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Graphite Bio, Inc. (NasdaqGM: GRPH) with LENZ Therapeutics. Under the terms of the proposed ...

Q32 Bio to take Homology Medicines' Nasdaq spot to fund PhII trials in autoimmune, inflammatory conditions - Vimarsana News

Q32 Bio to take Homology Medicines' Nasdaq spot to fund PhII trials in autoimmune, inflammatory conditions

The re­verse merg­ers are flow­ing. Q32 Bio will take Ho­mol­o­gy Med­i­cines’ place on the Nas­daq, the com­pa­nies said Thurs­day morn­ing, and the…

Source: biztoc.com
Shareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ Therapeutics - Vimarsana News

Shareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ Therapeutics

/PRNewswire/ -- Ademi LLP is investigating Graphite Bio (NASDAQ: GRPH) for possible breaches of fiduciary duty and other violations of law in its transaction...